Tuesday, April 15, 2025

Autonomous Medical Devices Incorporated Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular Diagnostics

Autonomous Medical Devices Incorporated announced the launch of its newest innovation, the Autolab™ HBH system, at the ESCMID Global Congress 2025 in Vienna. This breakthrough in sample preparation technology is designed to simplify and accelerate molecular workflows across a wide range of research and diagnostic settings.

The Autolab™ HBH platform utilizes AMDI’s proprietary Hyperbaric Heating (HBH) technology to rapidly lyse samples and access nucleic acids—without the need for conventional extraction kits that typically require 20-45 minutes of processing time and many manual steps. Autolab HBH processes samples in less than 2 minutes and gives a fast, cost-effective, and high yield alternative that empowers laboratories to move from sample to result with greater efficiency.

Also Read: Culture Biosciences Unveils Stratyx™ 250: The First Cloud-Integrated, Mobile Bioreactor for Accelerated Cell Culture Development

“The Autolab™ HBH system was developed to overcome the longstanding challenges in sample prep—namely complexity, cost, and time,” said David Okrongly, CEO of AMDI. “This launch reflects our ongoing mission to deliver advanced tools that generalize and thus improve molecular laboratory workflows and enable broader access to high-quality molecular testing, from PCR to sequencing.”

Autolab™ HBH also supports sample preparation from a variety of different sample matrices, making it equally valuable in clinical research, public health, environmental monitoring, and more. It is currently available for research use only (RUO).

SOURCE: PRNewswire

Subscribe Now

    Hot Topics